Fallopian Tube Cancer Market - Size, Share, Outlook, and Forecast till 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Fallopian Tubes also called as uterine tube are pair of tubes, which carry an egg from the ovary to the uterus. Fallopian tube cancer also called as tubal cancer is caused due to uncontrolled growth of cells in fallopian tubes that connect the ovaries and the uterus. This is very rare type of cancer and it is characterized by symptoms such as abnormal vaginal bleeding, especially after menopause, abdominal pain or a feeling of pressure in the abdomen, abnormal vaginal discharge that is white, clear or pinkish, and pelvic mass at the time of diagnosis. Although fallopian tube cancer can occur at any age, it majorly affects women between the ages of 50 and 60, age. Also, it is more common in Caucasian women who had few or no children.

Increasing prevalence of gynecological and reproductive disorders such as breast cancer, endometrial cancer, cervical cancer, ovarian cancer, and vaginal cancer is key factor fueling growth of the fallopian tube cancer market. Previous research studies reported that women who have inherited the gene linked to breast and ovarian cancer, called BRCA1, are show an increased risk of developing fallopian tube cancer. According to the article published in the University of California San Francisco, fallopian tube cancer is rare and accounts for 2 percent of all gynecologic cancers. Around 1,500 to 2,000 cases of fallopian tube cancer have been reported worldwide. An estimated 300 to 400 women are diagnosed with the condition annually in the U.S.

Key Developments in Fallopian Tube Cancer Market

Market players are engaged in developing novel drugs for treatment of fallopian tube cancer in order to meet increasing demand from healthcare sector, which in turn is driving growth of the fallopian tube cancer market size. Furthermore, launch and novel drugs to treat the fallopian cancer and their approval by regulatory bodies is boosting growth of the fallopian tube cancer market. For instance, in June 2018, the Genentech, biotechnology company received Food and Drug Administration (FDA) approval for combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer following initial surgical resection. Key players operating in fallopian tube cancer market include AbbVie Inc, Amgen Inc, Arrien Pharmaceuticals LLC, AstraZeneca Plc., Atara Biotherapeutics Inc, Bayer AG, BeiGene Ltd, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Co, Caladrius Biosciences Inc, Celgene Corp, Celldex Therapeutics Inc, Dr. Reddy’s Laboratories Ltd, Eisai Co Ltd, Eli Lilly and Co, EpiThany Inc, Exelixis Inc, F. Hoffmann-La Roche Ltd among others.

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.


Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.


Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection


© 2022 Worldwide Market Reports. All Rights Reserved